Group Disability Insurance Heads Into a Countercyclical Claims Turn

Group disability new premium fell 15% in the first quarter of 2025 and stayed down 3% to 6% through the third, even as LIMRA projects U.S. employment growth below 1% annually through 2028 (LIMRA, Q1 and Q3 2025; LIMRA, 2026). That combination shrinks the insured payroll base at the same time disability incidence, historically countercyclical, tends to climb as labor markets soften.

A Payroll-Linked Exposure Base That Has Stopped Growing

Group short-term and long-term disability premium is priced per $100 of covered payroll, so the insured exposure base expands only as fast as the employer groups underneath it add headcount and raise wages. The U.S. Bureau of Labor Statistics projects total employment will grow a cumulative 3.1% from 2024 to 2034, adding 5.2 million jobs, a sharp deceleration from the 13.0% growth the economy posted over 2014 to 2024 (BLS, 2025). LIMRA's own 2026 workplace-benefits research sharpens that same deceleration into a nearer-term number: annual employment growth below 1% from 2026 through 2028, alongside an unemployment rate that has already climbed to 4.9% in 2025 (LIMRA, 2026). For a line of business whose growth mechanics assume a steadily expanding covered population, a multi-year stretch of sub-1% employment growth is closer to a flat exposure base than a slowing one.

The sales data already shows the strain. Total workplace disability new premium was $1.6 billion in the first quarter of 2025, down 15% year over year, with short-term disability off 13% and long-term disability off 16% (LIMRA, Q1 2025). The decline moderated through the year: new premium came in at $620 million in the third quarter, down 3% year over year, with short-term disability down just 1% and long-term disability down 6% (LIMRA, Q3 2025). Nine-month 2025 volume totaled $3.0 billion, down 5% year over year, with the top 10 carriers writing 74% of that new premium (LIMRA, Q3 2025), a concentration that puts a shrinking pool of new business, and the countercyclical claims risk that rides with it, on fewer books than the market's carrier count would suggest.

What complicates a simple "premium falls with payroll" read is that LIMRA itself does not forecast disability in-force premium to fall in step with new sales. The same 2026 outlook that flags sub-1% employment growth also projects short- and long-term disability in-force premium growth staying closer to recent norms, even as life insurance in-force growth falls below its historical average (LIMRA, 2026). That gap between a soft new-sales quarter and a steadier in-force trajectory is a renewal-pricing story, not a volume story: carriers can hold in-force premium up through persistency and rate action on the existing block even while the market for new covered lives contracts, which is exactly the dynamic that pushes the claims-side pressure described below onto pricing actuaries working the 2027 renewal cycle rather than onto new-business underwriters.

The Aggregate Forecast Hides a Wide Spread by Industry

A sub-1% employment growth rate is an economy-wide average, and the industry detail behind BLS's 2024-2034 projections shows the growth concentrating unevenly. Healthcare and social assistance is projected to add jobs faster than any other sector, up 8.4% over the decade, with professional, scientific, and technical services up 7.5% and information up 6.5%, both driven in part by AI-related hiring (BLS, 2025). Sectors with flatter or shrinking headcount projections, including manufacturing and large segments of retail, sit well below the 3.1% economy-wide figure. A group disability block concentrated in an employer segment tracking the aggregate forecast carries materially different exposure-base and incidence risk than one concentrated in an employer segment tracking the healthcare or technology growth rate, and a carrier's own book mix, not the LIMRA or BLS topline number, determines which side of that spread its 2027 pricing needs to reflect. That dispersion is also where the countercyclical incidence mechanism bites hardest: employer segments with flat or negative headcount growth are the ones generating the layoffs that historically drive claims filing behavior up, compounding the exposure-base problem rather than offsetting it.

Why Disability Incidence Tends to Rise When Employment Growth Falls

Disability claim incidence does not move independently of the labor market, and it does not move in the direction intuition suggests. Academic research on the 2001 and 2008-09 recessions found that Social Security Disability Insurance applications and awards are countercyclical: claiming activity rises as unemployment rises, even though there is little evidence that the underlying incidence of severe disability itself increases during a downturn (NBER Working Paper 19672, 2013; RAND Working Paper WR-1088). The mechanism is behavioral rather than medical. A worker with a health impairment who would otherwise stay employed faces a lower opportunity cost of filing once a job is lost, particularly for programs like SSDI that require earnings below a substantial-gainful-activity threshold (NBER, 2013).

Group long-term disability carries an analogous but distinct version of the same mechanism. RGA's review of the 2008-09 downturn found that new LTD claim submissions initially dipped as employees clung to jobs or lost them too abruptly to file, but then rose and stayed elevated for years before returning to pre-recession levels (RGA, 2020). That lag matters for a reserving actuary: a softening labor market does not show up as an immediate incidence spike in the current accident quarter so much as a multi-year elevation that a triangle built on 2021-2024 experience will not anticipate. Layered on top of the incidence channel is a duration channel operating on the claims already open. Research on SSDI benefit terminations found post-termination earnings negatively correlated with the unemployment rate for all termination reasons, with medical-improvement terminations more sensitive to labor-market conditions (a -0.88 coefficient) than work-based terminations (-0.73), evidence that a weaker job market erodes a recovered claimant's ability to re-enter work even after medical improvement is established (SSA Social Security Bulletin, 2011).

Claim Termination Rates Are the Reserve-Side Casualty

Group LTD claim reserves are built from company-specific claim continuance and termination tables, not a single statutory morbidity table, since group business is priced and reserved off carrier-specific experience studies rather than the individual-market 2013 IDI Valuation Table the NAIC adopted in 2016 to replace the 1985 CIDA and CIDC tables (American Academy of Actuaries, 2016). That means the assumption most exposed to a softening labor market, the claim termination rate, is exactly the one an internal experience study will be slowest to pick up, because it is built on emerging experience from a period when return-to-work options were more plentiful. RGA's assessment of the last comparable downturn found claim termination rates deteriorated during the recession itself and rebounded only once the recovery took hold (RGA, 2020), which is the pattern a reserving actuary needs to anticipate rather than confirm after the fact: fewer open graded and part-time return-to-work placements, slower vocational rehabilitation referrals, and longer average claim duration on the block of business already on the books, independent of anything happening to new-claim incidence.

The reserve arithmetic runs in one direction when the termination rate assumption softens. A lower expected claim termination rate lengthens projected claim duration, which raises the present value of expected future benefit payments for every open claim, and it does so without requiring a single new incidence event. For a book where nine-month 2025 new premium is already down 5% year over year (LIMRA, Q3 2025), a reserving actuary who holds claim termination assumptions flat through 2026 and 2027 on the argument that the shrinking new-business volume offsets the risk is solving for the wrong side of the balance sheet. The exposure that matters for reserve adequacy is the claims already open, not the claims not yet sold.

Mental Health's Claim Share and the 24-Month Limitation

Mental and nervous disorders accounted for 9% of new long-term disability claims in the most recent Integrated Benefits Institute Health and Productivity Benchmarking data, cited by the Council for Disability Income Awareness, behind musculoskeletal disorders at 26%, cancer at 15%, and injuries at 11% (CDA/IBI, 2024 data released fourth quarter 2025). That U.S. figure sits well below the roughly 40% share Canadian carriers have reported in claims tracked from 2023 through 2025, a gap that reflects differences in plan design and claim-coding practice as much as underlying morbidity, but the direction of travel, a rising mental-health share of new claims, is consistent across both markets. LIMRA's own generational research found younger workers already prioritizing mental health benefits alongside life insurance and caregiving support, a preference pattern LIMRA's Bryan Hodgens attributed to the demands of "raising their children and caring for their aging parents and grandparents" (LIMRA, 2026), the same cohort most exposed to layoffs in a labor market growing below 1% a year.

Most group LTD contracts cap benefits for mental-health and self-reported-symptom claims at 24 months, a limitation that has functioned for decades as an actuarial governor on the tail duration and severity of that claim category specifically. That governor is now a live legislative target: the Workers' Disability Benefits Parity Act of 2025 (H.R. 3758), introduced in Congress in June 2025, would bar disability plans from applying limitations to mental-health or substance-use claims that are more restrictive than those applied to physical conditions. The bill has not been enacted, but it arrives in the same window covered in this site's reporting on the 2024 mental health parity rule's suspension and the actuarial liability gap it left behind, and it is a second, disability-specific front on the same underlying question: whether a benefit-limitation structure that carriers have priced against for years survives a period when both claim volume and legislative pressure are moving against it at once.

Quarterly New Premium Softened Through 2025 Before Employment Growth Even Slowed to LIMRA's Forecast Range

The first-quarter decline, a 15% drop against a prior-year comparison that still reflected a tighter labor market, is the sharpest swing in the series, and it landed before the sub-1% employment growth window LIMRA now projects for 2026 through 2028 had even begun (LIMRA, Q1 2025; LIMRA, 2026). New premium recovered to a modest 3% gain in the second quarter before turning down 3% again in the third, with long-term disability lagging short-term disability in every quarter reported (LIMRA, Q2 and Q3 2025). That LTD-specific softness is worth isolating: long-term disability is the product where the countercyclical incidence and claim-duration mechanics described above have the longest reserve tail, so a new-business line that is contracting faster than short-term disability is contracting is the line least able to grow its way out of a claims-side deterioration through fresh, better-priced business.

What 2027 Rate Filings and Reserve Reviews Should Build In

Health care cost trend adds a second pressure that compounds rather than offsets the employment-side squeeze. LIMRA's 2026 outlook projects an 8% increase in employer health care costs for 2026 absent plan design changes, and the Milliman Medical Index put 2026 employer-sponsored per-person cost growth at 7.9%, the steepest MMI increase in more than a decade outside pandemic-era distortion, pushing average per-person employer costs to $8,460 (LIMRA, 2026; Milliman Medical Index, May 2026). Rising medical cost trend does not price directly into disability rates the way it does into medical or stop-loss coverage, a dynamic this site examined in its analysis of the 9% group medical cost trend PwC projects for 2027 rate filings, but it operates on disability indirectly: costlier, harder-to-access care lengthens the interval between a short-term disability claim's onset and a claimant's medical clearance to return to work, which raises the share of STD claims that convert to LTD once STD benefits are exhausted, the same claim-duration channel a softer labor market is already stressing from the employment side. Medical stop-loss underwriters are living a parallel version of this problem now, tracked in this site's coverage of the structural break between stop-loss premium growth and seven-figure claim severity, where attachment points set against an older cost-trend baseline are already exposed; group disability's exposure runs through claim duration rather than claim severity, but the underlying driver, a cost trend outrunning the assumptions embedded in prior pricing, is the same one.

Three assumptions in a 2027 group disability rate filing or reserve review carry the weight of this analysis. Incidence assumptions built off 2021-2024 experience understate what a multi-year stretch of sub-1% employment growth has historically produced, since the countercyclical claiming pattern documented across the 2001 and 2008-09 downturns takes years to show up in a triangle and years longer to recede (NBER, 2013; RGA, 2020). Claim termination assumptions carry the more immediate reserve exposure, because a deteriorating return-to-work environment lengthens duration on claims already open regardless of what happens to new sales, and internal experience studies built on a more liquid labor market will lag that deterioration rather than lead it. And the mental-health claim segment, a comparatively small 9% share of new claims today but one carrying both a rising trend line and an active legislative threat to the 24-month limitation that has priced it for years, is the piece of the book where a reserve margin held flat through 2027 is the assumption most likely to be tested first.